Silo Wellness Inc. (CNSX: SILO)
Health Care · Pharmaceuticals · CA
CA$—
— today · — 1Y
Silo Wellness Inc. (CNSX: SILO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.14M.
trading between 0.01 and 0.04.
Tweenvest scores Silo Wellness Inc. across four factors: quality 8/100. Its strongest factor is quality.
SILO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.14M
- Revenue (TTM)
- $275.89K
- P/E
- 1.13
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- 0.78
- 52-week high
- CA$0.04
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 154.48M
- Employees
- —
- Next earnings
- —
About Silo Wellness Inc.
Based in Toronto, Canada, Silo Wellness Inc. is a company operating in the psychedelics and wellness sector, dedicated to advancing psychedelic medicines for trauma reduction. The firm produces and markets psilocybin-free functional mushroom tinctures, while also working on the formulation of a psilocybin nasal spray in Jamaica. Its extensive offerings include a range of functional mushroom products, the operation of psychedelic wellness retreats located in both Jamaica and Oregon, cultivation of psychedelic mushrooms and truffles within Jamaica, and the development of brick-and-mortar smart shops on the island. The company underwent a name change from Yukoterre Resources Inc. to Silo Wellness Inc. on February 26, 2021.
- ISIN
- CA8271242072
- Listed since
- Mar 8, 2021
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.